Quick Answer
ProPhase Labs, Inc. reported Earnings Per Share Diluted of $2.61 (loss) per share for the year ending 2024.
- ProPhase Labs, Inc. showed a decrease of -166.3% in Earnings Per Share Diluted from 2023 to 2024.
- This data is from ProPhase Labs, Inc.'s annual report (Form 10-K), filed with the SEC on April 1, 2025.
- XBRL data for this metric is available from 2013 to 2024 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2013 to 2024), ProPhase Labs, Inc.'s Earnings Per Share Diluted has declined by 8,800.0%.
- Historical annual values: Fiscal year 2024: $2.61 (loss) per share | Fiscal year 2023: $0.98 (loss) per share | Fiscal year 2022: $1.02 per share | Fiscal year 2021: $0.40 per share | Fiscal year 2020: $0.18 (loss) per share | Fiscal year 2018: $0.15 (loss) per share | Fiscal year 2017: $2.59 per share | Fiscal year 2016: $0.17 (loss) per share | Fiscal year 2015: $0.22 (loss) per share | Fiscal year 2014: $0.47 (loss) per share | Fiscal year 2013: $0.03 per share.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: